However, analysis of the activation markers (CD64, PD-L1), co-stimulatory molecules (CD80) and antigen-presenting molecules (MHC-I and MHC-II) on myeloid cells revealed profound differences between tumor-bearing WT and Clec4a2−/− mice. This evidence concerns the gene CD80 and neoplasm.